abstract |
The present invention relates to meta l-phthalocyanines bearing at least a group containing boron isotopes <11>B or <10>B, covalently bound to the peripheral positions of meta l-phthalocyanine nucleus; moreover it refers to the processes for their preparation, the pharmaceutical compositions comprising them and their use for the treatment of neoplastic and dysplastic pathologies. |